Lynn M. Gorham

624 total citations
9 papers, 542 citations indexed

About

Lynn M. Gorham is a scholar working on Oncology, Pharmacology and Hematology. According to data from OpenAlex, Lynn M. Gorham has authored 9 papers receiving a total of 542 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Pharmacology and 3 papers in Hematology. Recurrent topics in Lynn M. Gorham's work include Platelet Disorders and Treatments (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (2 papers). Lynn M. Gorham is often cited by papers focused on Platelet Disorders and Treatments (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (2 papers). Lynn M. Gorham collaborates with scholars based in United States. Lynn M. Gorham's co-authors include Thomayant Prueksaritanont, Kamlesh P. Vyas, Jerome Hochman, Donald E. Slaughter, Byron H. Arison, Bennett Ma, Xiaoming Yu, Lida Liu, Joan D. Ellis and George D. Hartman and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmaceutical Sciences and Drug Metabolism and Disposition.

In The Last Decade

Lynn M. Gorham

9 papers receiving 518 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lynn M. Gorham United States 7 247 225 132 84 84 9 542
Donald E. Slaughter United States 10 242 1.0× 140 0.6× 122 0.9× 111 1.3× 58 0.7× 12 583
Chang‐Woo Yeo South Korea 14 245 1.0× 200 0.9× 82 0.6× 76 0.9× 67 0.8× 23 536
Karl-Fr. Sewing Germany 10 188 0.8× 202 0.9× 206 1.6× 145 1.7× 167 2.0× 12 710
Mikael S. Thomsen Denmark 14 304 1.2× 172 0.8× 47 0.4× 129 1.5× 94 1.1× 25 751
Francis Heitz Switzerland 8 207 0.8× 213 0.9× 164 1.2× 200 2.4× 118 1.4× 8 855
J. Frederick Pritchard United States 15 149 0.6× 203 0.9× 135 1.0× 194 2.3× 68 0.8× 31 755
C A Duncan United States 8 179 0.7× 116 0.5× 225 1.7× 169 2.0× 48 0.6× 13 601
Xavier Boulenc France 15 336 1.4× 303 1.3× 45 0.3× 198 2.4× 94 1.1× 19 814
Amarjit S. Chaudhry United States 17 308 1.2× 207 0.9× 75 0.6× 182 2.2× 141 1.7× 20 737
Nobuyuki Murayama Japan 12 136 0.6× 182 0.8× 36 0.3× 117 1.4× 106 1.3× 16 486

Countries citing papers authored by Lynn M. Gorham

Since Specialization
Citations

This map shows the geographic impact of Lynn M. Gorham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynn M. Gorham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynn M. Gorham more than expected).

Fields of papers citing papers by Lynn M. Gorham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynn M. Gorham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynn M. Gorham. The network helps show where Lynn M. Gorham may publish in the future.

Co-authorship network of co-authors of Lynn M. Gorham

This figure shows the co-authorship network connecting the top 25 collaborators of Lynn M. Gorham. A scholar is included among the top collaborators of Lynn M. Gorham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynn M. Gorham. Lynn M. Gorham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Vickers, S., Anthony D. Theoharides, Byron H. Arison, et al.. (1999). In Vitro and In Vivo Studies on the Metabolism of Tirofiban. Drug Metabolism and Disposition. 27(11). 1360–1366. 32 indexed citations
2.
Prueksaritanont, Thomayant, Lynn M. Gorham, Bennett Ma, et al.. (1998). In vitro and in vivo evaluations of intestinal barriers for the zwitterion L-767,679 and its carboxyl ester prodrug L-775,318. Roles of efflux and metabolism.. PubMed. 26(6). 520–7. 20 indexed citations
3.
Prueksaritanont, Thomayant, Lynn M. Gorham, & K. C. Yeh. (1997). Analysis of Metabolite Kinetics by Deconvolution and in Vivo−in Vitro Correlations of Metabolite Formation Rates: Studies of Fibrinogen Receptor Antagonist Ester Prodrugs. Journal of Pharmaceutical Sciences. 86(12). 1345–1351. 3 indexed citations
4.
Prueksaritanont, Thomayant, Lynn M. Gorham, Bennett Ma, et al.. (1997). In vitro metabolism of simvastatin in humans [SBT]identification of metabolizing enzymes and effect of the drug on hepatic P450s.. PubMed. 25(10). 1191–9. 244 indexed citations
5.
Prueksaritanont, Thomayant, Lynn M. Gorham, Michael J. Breslin, et al.. (1997). In vitro and in vivo evaluations of the metabolism, pharmacokinetics, and bioavailability of ester prodrugs of L-767,679, a potent fibrinogen receptor antagonist: an approach for the selection of a prodrug candidate.. PubMed. 25(8). 978–84. 5 indexed citations
6.
Bednar, Rodney A., Bohumil Bednář, David A. Claremon, et al.. (1997). Non-Peptide Glycoprotein IIb/IIIa Inhibitors. 17. Design and Synthesis of Orally Active, Long-Acting Non-Peptide Fibrinogen Receptor Antagonists. Journal of Medicinal Chemistry. 40(12). 1779–1788. 49 indexed citations
7.
Prueksaritanont, Thomayant, et al.. (1997). Disposition of L-738,167, a potent and long-acting fibrinogen receptor antagonist, in dogs. Dose-dependent pharmacokinetics.. PubMed. 25(3). 355–61. 6 indexed citations
8.
Prueksaritanont, Thomayant, Lynn M. Gorham, Joan D. Ellis, et al.. (1996). Species and organ differences in first-pass metabolism of the ester prodrug L-751,164 in dogs and monkeys. In vivo and in vitro studies.. Drug Metabolism and Disposition. 24(11). 1263–1271. 6 indexed citations
9.
Prueksaritanont, Thomayant, et al.. (1996). Comparative studies of drug-metabolizing enzymes in dog, monkey, and human small intestines, and in Caco-2 cells.. Drug Metabolism and Disposition. 24(6). 634–642. 177 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Donald E. Slaughter Breakdown of academic impact, for papers by Chang‐Woo Yeo Breakdown of academic impact, for papers by Karl-Fr. Sewing Breakdown of academic impact, for papers by Mikael S. Thomsen Breakdown of academic impact, for papers by Francis Heitz Breakdown of academic impact, for papers by J. Frederick Pritchard Breakdown of academic impact, for papers by C A Duncan Breakdown of academic impact, for papers by Xavier Boulenc Breakdown of academic impact, for papers by Amarjit S. Chaudhry Breakdown of academic impact, for papers by Nobuyuki Murayama
Rankless by CCL
2026